Pediatric hematology-oncology outreach for developing countries

被引:38
|
作者
Wilimas, JA
Ribeiro, RC
机构
[1] St Jude Childrens Res Hosp, Int Outreach Program, Dept Hematol Oncol, Memphis, TN 38105 USA
[2] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA
关键词
D O I
10.1016/S0889-8588(05)70246-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pediatric cancer is highly curable in developed countries. Cure rates approach 90% for some tumors, and the overall cure rate has reached 75%.(11) In developing countries, however, cure rates may reach only 25% at best. There are an estimated 210,000 new cases of childhood cancer per year worldwide, and more than 80% of these cases occur in countries that lack the resources to provide treatment.(7) As shown in Figure 1, this disparity results in a worldwide cure rate of only 33% for childhood cancer. Additionally, as infant mortality and death from infectious diseases have decreased in developing countries, cancer has become a more prominent cause of childhood mortality. In Latin America, Thailand, India, and China, cancer has become a leading cause of death among children 5 to 15 years old. (14) To address these inequities, institutions and organizations throughout the world are initiating international outreach programs. These efforts are often fragmented, and little information about them is available in the medical literature. This article describes several initiatives throughout the world, outlines the International Outreach Program at St. Jude Children's Research Hospital, and offers some suggestions for programs aimed at addressing this significant problem.
引用
收藏
页码:775 / +
页数:14
相关论文
共 50 条
  • [1] Department of pediatric hematology-oncology in Crete
    Kalmanti, M
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1996, 13 (05) : 397 - 399
  • [2] Vancomycin use in pediatric hematology-oncology patients
    Hopkins, HA
    Sinkowitz-Cochran, RL
    Rudin, BA
    Keyserling, HL
    Jarvis, WR
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (01): : 48 - 50
  • [3] Application of Flow Cytometry in Pediatric Hematology-Oncology
    Varma, Neelam
    Naseem, Shano
    PEDIATRIC BLOOD & CANCER, 2011, 57 (01) : 18 - 29
  • [4] Academic training pathways in pediatric hematology-oncology
    Sakamoto, Kathleen M.
    PEDIATRIC BLOOD & CANCER, 2006, 47 (03) : 239 - 241
  • [5] Establishing a Pediatric Hematology-Oncology Program in Botswana
    Slone, Jeremy S.
    Slone, Amanda K.
    Wally, Oaitse
    Semetsa, Pearl
    Raletshegwana, Mpho
    Alisanski, Susan
    Force, Lisa M.
    Chinyundo, Kamusisi
    Margolin, Judith
    Agrawal, Anurag K.
    Anderson, Alan R.
    Scheurer, Michael E.
    Mehta, Parth S.
    JOURNAL OF GLOBAL ONCOLOGY, 2018, 4 : 1 - 9
  • [6] Present status of pediatric hematology-oncology in China
    Lu, SG
    Tang, SQ
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1997, 14 (01) : 11 - 15
  • [7] Addressing implicit bias in pediatric hematology-oncology
    Tsai, Jessica W.
    Kesselheim, Jennifer C.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (05)
  • [9] Invasive aspergillosis in a pediatric hematology-oncology ward
    Lamalmi, F.
    Aghrouch, M.
    Benomar, A.
    Tligui, H.
    Agoumi, A.
    MEDECINE ET MALADIES INFECTIEUSES, 2012, 42 (06): : 280 - 282
  • [10] Maximizing the Impact of a Pediatric Hematology-Oncology Twinning Program
    Slone, Jeremy S.
    Slone, Amanda K.
    Mehta, Parth S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 (02) : 369 - 369